Department of Orthopaedics (Spine), Changhai Hospital, Shanghai, China.
Am J Ther. 2019 Jan/Feb;26(1):e38-e44. doi: 10.1097/MJT.0000000000000449.
Percutaneous vertebroplasty (PVP) can not only alleviate pain but also restore mechanical stability with injection of bone cement, whereas it exhibits a poor effect on antitumor activity. But through combinations with other therapies, it may be possible to achieve the maximum effect in clinical treatment. Thus, this study is designed to assess the clinical efficacy of PVP separately combined with 4 ways for spinal metastasis (SM) treatment.
Which combination treatment is better for spinal metastasis, percutaneous vertebroplasty with radiofrequency ablation, I seed, zoledronic acid or radiotherapy?
A total of 169 patients with SM were retrospectively recruited and randomly assigned to 4 groups to receive 4 different ways separately: 49 patients (group A) received PVP plus I seed, 51 (group B) received PVP plus radiofrequency ablation (RFA), 38 (group C) underwent PVP plus zoledronic acid (ZA), and 31 (group D) underwent PVP plus radiotherapy (RT).
All of them underwent routine examinations before operation. Visual analog scale (VAS), World Health Organization (WHO) Pain Relief, and ODI were applied to evaluate pain relief and motor function.
PVP plus RT achieved the best efficacy in relieving pains, with the highest WHO Pain Relief (P < 0.05). The PVP plus RFA exhibited lowest ODI, suggesting the best outcome after treatment (P < 0.05). The PVP plus I showed the lowest VAS score, but it was the worst to improve the routine exercise ability and relieve pains from patients. The PVP plus ZA presented higher VAS and ODI (P < 0.05).
PVP combined with I seed exhibited the best clinical efficacy in terms of VAS, PVP combined with RT was the best choice in terms of WHO Pain Relief, and PVP combined with RFA showed the best effect in terms of ODI for the treatment of SM.
经皮椎体成形术(PVP)不仅可以通过注射骨水泥来缓解疼痛,还可以恢复力学稳定性,但它在抗肿瘤活性方面效果较差。但是通过与其他治疗方法相结合,有可能在临床治疗中达到最大效果。因此,本研究旨在评估 PVP 分别与 4 种脊柱转移瘤(SM)治疗方法联合治疗的临床疗效。
经皮椎体成形术联合射频消融、放射性碘 125 粒子、唑来膦酸或放疗治疗脊柱转移瘤,哪种联合治疗效果更好?
回顾性招募了 169 例 SM 患者,将他们随机分配到 4 组,分别接受 4 种不同的治疗方法:49 例患者(A 组)接受 PVP 联合放射性碘 125 粒子治疗,51 例患者(B 组)接受 PVP 联合射频消融治疗,38 例患者(C 组)接受 PVP 联合唑来膦酸治疗,31 例患者(D 组)接受 PVP 联合放疗治疗。
所有患者在手术前均进行常规检查。采用视觉模拟评分(VAS)、世界卫生组织(WHO)疼痛缓解程度和 Oswestry 功能障碍指数(ODI)评估疼痛缓解和运动功能。
PVP 联合放疗在缓解疼痛方面效果最好,WHO 疼痛缓解程度最高(P < 0.05)。PVP 联合射频消融术后 ODI 最低,表明治疗后效果最佳(P < 0.05)。PVP 联合放射性碘 125 粒子治疗的 VAS 评分最低,但改善患者日常运动能力和缓解疼痛的效果最差。PVP 联合唑来膦酸治疗的 VAS 和 ODI 较高(P < 0.05)。
PVP 联合放射性碘 125 粒子在 VAS 方面显示出最佳的临床疗效,PVP 联合放疗在 WHO 疼痛缓解方面是最佳选择,PVP 联合射频消融在 ODI 方面显示出治疗 SM 的最佳效果。